Gencurix Inc. (KOSDAQ: 229000)
South Korea
· Delayed Price · Currency is KRW
1,934.00
-55.00 (-2.77%)
Nov 15, 2024, 9:00 AM KST
Gencurix Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 2,914 | 2,600 | 2,559 | 3,047 | 1,572 | 136.62 |
Revenue Growth (YoY) | 31.13% | 1.60% | -16.00% | 93.83% | 1050.64% | - |
Cost of Revenue | 1,202 | 1,252 | 1,402 | 6,025 | 2,822 | 128.55 |
Gross Profit | 1,712 | 1,348 | 1,158 | -2,978 | -1,250 | 8.07 |
Selling, General & Admin | 7,173 | 6,955 | 6,883 | 5,523 | 4,640 | 3,928 |
Research & Development | 4,292 | 4,529 | 4,181 | 3,475 | 3,154 | 1,811 |
Other Operating Expenses | 88.97 | 95.9 | 121.63 | 152.01 | 116.31 | 104.84 |
Operating Expenses | 13,130 | 13,724 | 12,668 | 9,767 | 8,016 | 6,568 |
Operating Income | -11,418 | -12,376 | -11,510 | -12,745 | -9,267 | -6,560 |
Interest Expense | -671.27 | -810.73 | -478.25 | -278.21 | -230.5 | -39.46 |
Interest & Investment Income | 165.13 | 260.32 | 198.43 | 156.03 | 29.71 | 4.72 |
Earnings From Equity Investments | - | - | -109.47 | -170.53 | 2,138 | 654.77 |
Currency Exchange Gain (Loss) | 0.86 | 0.21 | 56.16 | 70.86 | -65.43 | -1.38 |
Other Non Operating Income (Expenses) | -889.81 | -420.87 | -2,038 | 48.96 | -785.4 | 3.67 |
EBT Excluding Unusual Items | -12,813 | -13,347 | -13,881 | -12,918 | -8,180 | -5,937 |
Impairment of Goodwill | - | - | -3,191 | - | - | - |
Gain (Loss) on Sale of Investments | -2,340 | -6,878 | -8,403 | -22,525 | 42,083 | - |
Gain (Loss) on Sale of Assets | 15.32 | -83.18 | 15.44 | 15.69 | 15.73 | -17.09 |
Asset Writedown | 2.48 | 12.78 | 8.54 | 277.7 | -952.4 | -3,208 |
Pretax Income | -15,135 | -20,295 | -25,452 | -35,150 | 32,966 | -9,162 |
Income Tax Expense | -151.63 | -155.32 | -0.65 | -0.59 | 1.24 | - |
Earnings From Continuing Operations | -14,983 | -20,139 | -25,451 | -35,149 | 32,964 | -9,162 |
Minority Interest in Earnings | 736.04 | 879.36 | 853.95 | 479.29 | 143.93 | - |
Net Income | -14,247 | -19,260 | -24,597 | -34,670 | 33,108 | -9,162 |
Net Income to Common | -14,247 | -19,260 | -24,597 | -34,670 | 33,108 | -9,162 |
Shares Outstanding (Basic) | 14 | 12 | 8 | 7 | 6 | 5 |
Shares Outstanding (Diluted) | 14 | 12 | 8 | 7 | 6 | 5 |
Shares Change (YoY) | 49.48% | 43.64% | 26.37% | 3.85% | 16.29% | - |
EPS (Basic) | -1027.60 | -1629.25 | -2988.82 | -5323.76 | 5604.96 | -1699.00 |
EPS (Diluted) | -1027.60 | -1629.25 | -2989.00 | -5324.00 | 5398.76 | -1699.00 |
Free Cash Flow | -11,305 | -12,933 | -23,498 | -9,442 | -14,712 | -6,037 |
Free Cash Flow Per Share | -815.43 | -1094.00 | -2855.32 | -1449.82 | -2345.97 | -1119.44 |
Gross Margin | 58.76% | 51.85% | 45.23% | -97.73% | -79.53% | 5.91% |
Operating Margin | -391.78% | -475.93% | -449.69% | -418.29% | -589.48% | -4801.54% |
Profit Margin | -488.85% | -740.68% | -961.01% | -1137.86% | 2106.14% | -6706.46% |
Free Cash Flow Margin | -387.92% | -497.35% | -918.09% | -309.87% | -935.88% | -4418.77% |
EBITDA | -9,998 | -10,985 | -10,595 | -12,313 | -9,153 | -5,691 |
D&A For EBITDA | 1,420 | 1,391 | 914.25 | 431.99 | 113.96 | 869.26 |
EBIT | -11,418 | -12,376 | -11,510 | -12,745 | -9,267 | -6,560 |
Effective Tax Rate | - | - | - | - | 0.00% | - |
Advertising Expenses | - | 311.36 | 344.55 | 189.78 | 110.4 | 124.79 |
Source: S&P Capital IQ. Standard template. Financial Sources.